Skip to Main Content

Paper Details

CETP (Cholesteryl Ester Transfer Protein) Inhibition With Anacetrapib Decreases Production of Lipoprotein(a) in Mildly Hypercholesterolemic Subjects.
Arterioscler Thromb Vasc Biol
58
2017
2H3, Anacetrapib, CETP, Cholesteryl Ester, Cholesteryl Ester Transfer Protein, Lipoprotein(a), Lp(a), anacetrapib, aortic stenosis, apo(, apo(a), apoB, apolipoprotein (a), apolipoprotein B, atorvastatin, cardiovascular disease, cholesteryl ester, cholesteryl ester transfer protein, clinicaltrials, high-density lipoproteins, leucine, lipoprotein (a), participants, patients
Author NameAffiliation
Tiffany ThomasFrom the Columbia University, D.E.G.) University of Washington, Seattle (S.M.M.) and University of Pennsylvania
Santica M MarcovinaFrom the Columbia University, D.E.G.) University of Washington, Seattle (S.M.M.) and University of Pennsylvania
Daniel J RaderFrom the Columbia University, D.E.G.) University of Washington, Seattle (S.M.M.) and University of Pennsylvania
  • 1 - 3

Datasets

Release 1.2